- Home
- LOBO vs NEUP Comparison
LOBO vs NEUP Comparison
Compare LOBO & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOBO
- NEUP
- Stock Information
- Founded
- LOBO 2014
- NEUP 1996
- Country
- LOBO China
- NEUP United States
- Employees
- LOBO N/A
- NEUP N/A
- Industry
- LOBO
- NEUP
- Sector
- LOBO
- NEUP
- Exchange
- LOBO NYSE
- NEUP Nasdaq
- Market Cap
- LOBO 13.6M
- NEUP 12.7M
- IPO Year
- LOBO 2024
- NEUP N/A
- Fundamental
- Price
- LOBO $0.62
- NEUP $6.87
- Analyst Decision
- LOBO
- NEUP Strong Buy
- Analyst Count
- LOBO 0
- NEUP 1
- Target Price
- LOBO N/A
- NEUP $21.00
- AVG Volume (30 Days)
- LOBO 8.2M
- NEUP 29.5K
- Earning Date
- LOBO 04-29-2025
- NEUP 06-17-2025
- Dividend Yield
- LOBO N/A
- NEUP N/A
- EPS Growth
- LOBO N/A
- NEUP N/A
- EPS
- LOBO N/A
- NEUP 0.00
- Revenue
- LOBO $21,188,606.00
- NEUP $15,662,715.00
- Revenue This Year
- LOBO $77.34
- NEUP N/A
- Revenue Next Year
- LOBO N/A
- NEUP N/A
- P/E Ratio
- LOBO N/A
- NEUP $4,008.24
- Revenue Growth
- LOBO 36.92
- NEUP N/A
- 52 Week Low
- LOBO $0.46
- NEUP $2.90
- 52 Week High
- LOBO $3.52
- NEUP $126.00
- Technical
- Relative Strength Index (RSI)
- LOBO N/A
- NEUP N/A
- Support Level
- LOBO N/A
- NEUP N/A
- Resistance Level
- LOBO N/A
- NEUP N/A
- Average True Range (ATR)
- LOBO 0.00
- NEUP 0.00
- MACD
- LOBO 0.00
- NEUP 0.00
- Stochastic Oscillator
- LOBO 0.00
- NEUP 0.00
About LOBO LOBO EV TECHNOLOGIES LTD
Lobo EV Technologies Ltd is an electric vehicle manufacturer and seller company. It designs, develops, manufactures, and sells e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles such as golf carts and mobility scooters for the elderly and disabled persons, also provides automobile information and entertainment software development and design services to customers. The company operates in two operating segments: Electric vehicles and accessories sales which generates key revenue, and software royalties and development and design services. It generates all of its revenue within the People's Republic of China.
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.